A San Francisco health benefits startup emerged from Y Combinator this summer with an audacious pitch: slash employer insurance costs by 20 to 50 percent while offering zero-deductible plans and trendy GLP-1 weight-loss drugs. What Prescience hasn't done is name a customer or produce third-party proof that its model works.
The timing, at least, is opportune. Employers are bracing for health benefit costs to climb 6.5 to 6.7 percent in 2026, the sharpest jump in 15 years, according to projections Mercer published earlier this year. KFF reported in October that the average family premium in 2025 was $26,993, with workers themselves shouldering $6,850 of that tab.
Prescience positions itself as an administrative services provider rather than an insurance carrier, handling the messy back-office work of claims processing, regulatory filings, and payroll integration for companies that self-fund their health plans. Its website describes real-time claims adjudication and compliance management, the kind of infrastructure that typically requires years to build and validate.
The company's flagship offering, which it calls the Diamond plan, dispenses with employee premiums entirely. Members pay $15 copays, face a $1,000 out-of-pocket cap, and receive employer-funded health savings accounts worth up to $1,700 annually. The package bundles in GLP-1 medications and promises same- or next-day access to care.
The AI Angle
Two AI systems anchor Prescience's approach. Crystal, a round-the-clock digital care companion, purportedly triages members in under eight minutes. Time Machine, built on reinforcement learning, attempts to predict individual health trajectories before costs spiral.
"We help cut premiums by 20%, offer $0 deductibles, include GLP-1s… and have no hidden fees: we're only paid when we save you money," Aditya Jain, the company's president and chief operating officer, wrote in its Y Combinator launch post. The company's homepage displays illustrative projections showing costs of $847 per member per month versus a $1,213 market average, though its own savings calculator cautions that the estimates are based on assumptions about typical professional employer organization premiums.
A job posting on the company's site claims Prescience raised seed funding at a $150 million valuation from Bain Capital Ventures, Conviction, Pear VC, Greycroft, and Y Combinator itself, though the company declined to confirm the round when contacted. No press releases or venture database entries support the claim, leaving the company's actual funding status unclear.
CEO and co-founder Rishab Jain previously studied computer science and neuroscience at Harvard and exited an education technology venture before launching Prescience. The Y Combinator directory lists just five employees in its most recent batch.
Crowded Territory
Prescience is wading into a market thick with competitors pursuing variations on the same theme. Collective Health administers plans for self-funded employers. Centivo emphasizes tightly managed primary-care networks for mid-sized groups. Sana Benefits courts small businesses with self-funded and level-funded arrangements. ICHRA administration platforms such as Thatch and Take Command have also staked claims in the startup and small-business segments Prescience is eyeing.
For health care providers, Prescience promises to eliminate prior authorization headaches, process payments within three business days, and offer what it calls Predictive Pay, which advances money for anticipated procedures. Whether doctors and hospitals will trust a fledgling startup with unproven cash flow remains an open question.
Show, Don't Tell
"Prescience flips the incentive. They're only paid when they save you money," Ankit Gupta, a Y Combinator partner, wrote on LinkedIn shortly after the launch. The company has been soliciting introductions to CFOs and benefits leaders mapping out their health plans for the coming year.
But the central savings claim still lacks outside corroboration. Prescience has published no customer names, no case studies, no audited outcomes. RuntimeWire noted the absence of external validation when the startup launched. Months later, that gap persists.
In an industry where trust is earned through years of claims data and actuarial scrutiny, Prescience is asking employers to bet on a promise. The company may well deliver on its pitch. For now, though, the evidence remains somewhere between aspirational and invisible.
